Cargando…

Myasthenia gravis and paroxysmal nocturnal hemoglobinuria after thymectomy: A rare association

Paroxysmal nocturnal hemoglobinuria (PNH) is a very rare clonal autoimmune disease manifesting with hemolysis, thrombosis, or bone marrow failure. We present an atypical association of myasthenia gravis, aplastic anemia, and PNH occurring years after thymectomy. While this association might be extre...

Descripción completa

Detalles Bibliográficos
Autores principales: Galtier, Jean, Duval, Fanny, Machelart, Irène, Greib, Carine, Lazaro, Estibaliz, Pellegrin, Jean‐Luc, Viallard, Jean‐François, de la Tour, Regis Peffault, Rivière, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176050/
https://www.ncbi.nlm.nih.gov/pubmed/35845222
http://dx.doi.org/10.1002/jha2.244
Descripción
Sumario:Paroxysmal nocturnal hemoglobinuria (PNH) is a very rare clonal autoimmune disease manifesting with hemolysis, thrombosis, or bone marrow failure. We present an atypical association of myasthenia gravis, aplastic anemia, and PNH occurring years after thymectomy. While this association might be extremely rare, it may not be coincidental as there is a common pathophysiology between PNH and aplastic anemia, with the latter reported in several thymoma/thymectomy cases. Eculizumab was introduced with good efficacy and without safety concern in our patient, leading to long‐term control of PNH without worsening of myasthenia gravis.